Targeting the TREM2 molecular pathway may be an important therapeutic target to re-program hepatic macrophages to an immune regulatory phenotype and reduce the consequences of hypercholesterolemia in cholestasis. Here, TREM2 is linked to familial hypercholesterolemia.